683 Capital Management LLC Makes New Investment in Astria Th

683 Capital Management LLC purchased a new stake in shares of Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Rating) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 14,718 shares of the biotechnology company’s stock, valued at approximately $219,000. Several other […]

Related Keywords

United States , America , , Jump Financial , Dorsey Wright Associates , Capital Management , America Corp , Nasdaq , Securities Exchange Commission , Geode Capital Management , Astria Therapeutics Inc , Astria Therapeutics , Get Rating , Hereditary Angioedema , Visit Holdingschannel , Astria Therapeutics Daily , Nasdaq Atxs , Atxs , Medical , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,